Կարդիոնատ

main_info

  • trade_name:
  • Կարդիոնատ
  • dosage:
  • 100մգ/մլ(10/2x5/) ամպուլներ 5մլ, բլիստերում
  • pharmaceutical_form:
  • լուծույթ ներարկման
  • prescription_type:
  • Դեղատոմսով
  • medicine_domain:
  • Human
  • medicine_type:
  • Allopathic

documents

localization

  • country:
  • Կարդիոնատ
    አርሜኒያ
  • language:
  • አማርኛ

other_info

status

  • source:
  • Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում - Armenia
  • last_update:
  • 31-05-2018

24-4-2019

Efficacy of Saccharomyces cerevisiae NBRC 0203, Lactobacillus plantarum NBRC 3070 and Lactobacillus casei NBRC 3425 as a technological additive (silage additive) for all animal species

Efficacy of Saccharomyces cerevisiae NBRC 0203, Lactobacillus plantarum NBRC 3070 and Lactobacillus casei NBRC 3425 as a technological additive (silage additive) for all animal species

Published on: Tue, 23 Apr 2019 The product under assessment is a preparation containing single strains of Saccharomyces cerevisiae, Lactobacillus plantarum and Lactobacillus casei to be used as a technological additive to improve the ensiling process. EFSA has been previously requested by the European Commission to evaluate this product. The safety of the additive for consumers, users, the environment and target animals was established at that time. There was, evidence for improved aerobic stability in ...

Europe - EFSA - European Food Safety Authority EFSA Journal

21-2-2019


Info day for micro, small and medium-sized enterprises (SMEs): regulatory toolbox for medicines and combined devices developers, European Medicines Agency, London, UK, from 26/10/2018 to 26/10/2018

Info day for micro, small and medium-sized enterprises (SMEs): regulatory toolbox for medicines and combined devices developers, European Medicines Agency, London, UK, from 26/10/2018 to 26/10/2018

Info day for micro, small and medium-sized enterprises (SMEs): regulatory toolbox for medicines and combined devices developers, European Medicines Agency, London, UK, from 26/10/2018 to 26/10/2018

Europe - EMA - European Medicines Agency

14-3-2019

Webinar: Permitted indications for listed medicines

Webinar: Permitted indications for listed medicines

Webinar for small to medium businesses, start-ups, researchers and those new to regulation

Therapeutic Goods Administration - Australia

8-3-2019


News bulletin for small and medium-sized enterprises - Issue 46

News bulletin for small and medium-sized enterprises - Issue 46

News bulletin for small and medium-sized enterprises - Issue 46

Europe - EMA - European Medicines Agency

8-3-2019

'Drop-In Day' (Sydney)

'Drop-In Day' (Sydney)

An expression of interest for small to medium enterprises to meet with TGA specialists

Therapeutic Goods Administration - Australia